NAMSA – Medical Alley Association

NAMSA

In The Know: Healthcare News for May 17, 2021

Relievant Medsystems Names Tyler Binney President and CEO Value-Based Care Innovator Lifesprk to Acquire Tealwood Senior Living; Bill Thomas to Lead Creation of Operational Model Mayo Clinic, Kaiser Permanente Announce Strategic Investment in Medically Home to Expand Access to Serious or Complex Care at Home NAMSA in Growth Mode Under New Leadership Bigfoot Biomedical® Receives […]

Mergers & Acquisitions Drive More Than a Billion Dollars of Value in Medical Alley

More than a billion dollars of mergers and acquisitions and more than $347M million of public and private capital to fund new developments fueled a strong first quarter in Medical Alley. Boosted by the return of the Angel Tax Credit Program (ATCP), 43 companies raised $109 million in private capital and $238 million was raised […]

In The Know: Healthcare News for March 15, 2021

NAMSA Begins Next Chapter of Growth Under Newly Appointed CEO, Dr. Christophe Berthoux Best Hospitals 2021 – United States Jodi Hubler Rejoins Central Logic Board of Directors Boston Scientific Plans New Building on Maple Grove Campus ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business Medtronic Taps Walmart Exec […]

In The Know: Healthcare News for March 8, 2021

Acquisition by ArchiMed’s NAMSA Makes it the Preeminent Contract Research Organization for Medtech Lab Testing Nu-Tek BioSciences to Build Dedicated Animal-free Peptone Manufacturing Facility to service Growing Biologics Supply Chain Demands Best Buy Health Offers Lively Health & Safety Services On Apple Watch For First Time Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical […]

NAMSA Acquires Syntactx to Enhance End-to-End CRO Development Solutions

Acquisition Expands Medical Device Clinical Research Capabilities and Expertise. Today, it is with delight that I announce that NAMSA has acquired New York-based Clinical Research Organization (CRO), Syntactx. Founded in 2010, Syntactx has a rich history and proven track record of synthesizing clinical evidence for global medtech Sponsors to enable broad market adoption and commercial success […]

In the Know: Healthcare News for September 8, 2020

CMS agrees to cover ‘breakthrough’ medical devices New Technologies Are Ushering in the Biggest Revolution in Senior Care in Over a Century University of Minnesota’s microbiology research facility key to national ‘moonshot’ effort to fight COVID FDA approves Medtronic MiniMed 770G insulin pump for young children Baxter’s dialysis filter wins De Novo nod Like Nothing […]

Partnering with Existing Owners and Management, ArchiMed Acquires Majority Interest in NAMSA, the World Leader in Medical Device Testing

Investment to accelerate NAMSA’s global growth and strategic vision; NAMSA is the third acquisition of MED Platform I, ArchiMed’s recently closed €1 billion mid-cap buy-and-build fund for the healthcare sector. TOLEDO, OH and LYON, FRANCE—BusinessWire—September 1, 2020 – Private equity healthcare specialist ArchiMed has acquired from the founding Gorski Family a majority stake in NAMSA, the […]

Med-Tech Front Lines Against COVID-19 Includes Array of Minnesota-Connected Companies

Via Star Tribune “Minneapolis-based Bio-Techne is making analyzers to enable researchers to detect when a patient is having a medical emergency related to COVID-19. Eden Prairie-based CHF Solutions is shipping a device that removes excess fluids from intensive-care patients treated for COVID-19. National attention has fixed on Medtronic and its Puritan Bennett ventilators that supply […]

NAMSA is Committed to Client and Associate Health and Safety

Via NAMSA The health and wellbeing of our Clients, Associates, Partners and communities are top concerns for NAMSA, and we are closely monitoring the COVID-19 health situation currently impacting our global community. We understand that this unique time in history is full of uncertainty and concern. However, as in other times of health crises, we […]

Health care companies race to find test to quickly detect COVID-19

Via Minneapolis Star-Tribune “‘Usually, you’d be able to detect it pretty close to when symptoms appear, for most viruses,’” said David Deetz, CEO of St. Paul’s Ativa Medical, which is developing a point-of-care test for COVID-19 that is still months from commercial release. “‘That’s why no one can contain this thing. … You become contagious […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER